Publication | Open Access
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
119
Citations
13
References
2020
Year
The study provides Class IV evidence that immunodot assays for onconeural antibodies accurately identify patients with paraneoplastic neurologic syndromes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1